(Q38029111)

27 August 2017

title

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

27 August 2017

0 references

0 references

0 references

1 reference

J L Anderson

1

1 reference

27 August 2017

R J Edney

series ordinal

2

1 reference

27 August 2017

K Whelan

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

25 July 2012

1 reference

Alimentary Pharmacology & Therapeutics

27 August 2017

published in

1 reference

27 August 2017

volume

36

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

503-516

1 reference

Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Role of the microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

The intestinal microbiota and chronic disorders of the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

An evidence-based systematic review on medical therapies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Hospitalisations and surgery in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Probiotics in the treatment of human inflammatory bowel diseases: update 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Fecal microbiota transplantation and emerging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Review article: faecal transplantation therapy for gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Durable alteration of the colonic microbiota by the administration of donor fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Treatment of ulcerative colitis using fecal bacteriotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Reshaping the gut microbiome with bacterial transplantation and antibiotic intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Risk and rewards of fecal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Adverse events in randomized trials: neglected, restricted, distorted, and silenced.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Treating Clostridium difficile infection with fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05220.X

10.1111/J.1365-2036.2012.05220.X

21 January 2018

Identifiers

DOI

1 reference

release_par24fdngrebbbmiidoj73cwi4

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/par24fdngrebbbmiidoj73cwi4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference